Sanodyne Therapeutics, Inc.

United Statessanodynetherapeutics.com

Sanodyne Therapeutics, Inc. is a biopharmaceutical company focused on the research and development of novel therapeutics for neurology and pain-related conditions. The company advances drug candidates through preclinical and early clinical stages with the aim of addressing unmet medical needs in nerve-related disorders.

Sanodyne’s activities include translational research, clinical development, and collaboration with external partners through licensing and development agreements. Its work centers on building a pipeline of innovative therapies with the potential to improve outcomes for patients with neuropathic and other pain syndromes.

Latest news on Sanodyne Therapeutics, Inc.

25 November 2025
Toray Licenses Drug Candidate for Peripheral Neuropathy Treatment

Sanodyne gains rights to develop TRK-750 for neuropathy. SNT-001 shows promise in trials, with Phase II planned. Collaboration aims to advance treatment options.